Try our Advanced Search for more refined results

Analysis

Pharma M&A Surge Eases Biotech VC Exit Struggles

By Najiyya Budaly ( February 20, 2026, 2:02 PM GMT) -- Big pharmaceutical companies circling mature drug candidates as they seek to fill a revenue hole of more than $200 billion — created by a looming patent cliff — might provide respite to venture capital investors that have struggled to exit biotech companies since COVID-19, experts say....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies